LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3100
+0.0050 (1.64%)
Jun 30, 2026, 2:35 PM EST
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 38.18 million as of July 1, 2026. Its market cap has decreased by -15.25% in one year.
Market Cap
38.18M
Enterprise Value
59.79M
Revenue
26.80M
Ranking
n/a
PE Ratio
13.88
Stock Price
0.31
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 38.18M, a decrease of -38.08%. That is a compound annual growth rate of -13.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 38.18M | -10.00% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Planet 13 Holdings | 60.36M |
| Vext Science | 59.44M |
| BioNxt Solutions | 48.98M |
| C21 Investments | 41.54M |
| ZYUS Life Sciences | 39.86M |
| Optimi Health | 33.47M |
| Mountain Valley MD Holdings | 31.99M |
| Voyageur Pharmaceuticals | 31.69M |